Navigation Links
Accumed Research Associates Featured On Katz's Corner 77 WABC Radio Show To Discuss Enlarged Prostate Treatment and Clinical Trials In Urology
Date:1/13/2014

Garden City, New York (PRWEB) January 13, 2014

Mitchell Efros MD FACS, President and Medical Director of Accumed Research Associates appeared on Katz's Corner News Talk Radio 77 WABC to discuss clinical research as an option for medical care. Visit Katz's Corner Accumed Research January 14, 2014 and listen to the January 12th, 2014 podcast to hear the entire broadcast.

Accumed Research Associates offers enlarged prostate (BPH) treatment for men that experience symptoms. The various clinical trials may provide novel therapeutic alternatives for men suffering with urinary problems referred to as lower urinary tract symptoms (LUTS). The clinical trials offered are for men who are naive to treatment and those that have tried other therapies other than surgery before. Accumed Research Associates provides enlarged prostate (BPH) treatment on Long Island, New York.

Accumed Research Associates also conducts clinical trials for men with low testosterone, prostate cancer, men and women with overactive bladder and urinary incontinence or frequent urination, as well as healthy volunteer studies. Dr. Efros reviewed the steps necessary to participate in a clinical trial and how clinical trials advance medical therapy and bring potential added value to the patient.

Dr. Mitchell Efros MD FACS, Medical Director and President of Accumed Research Associates stated, "Clinical trials provide alternatives to the standard forms of therapy that are currently available."

About Accumed Research Associates:
Accumed Research Associates has been providing expert urologic care for over 14 years by a board certified urologist and seasoned compassionate healthcare providers. Located in Garden City, New York Accumed Research Associates provides alternatives and cutting edge medication and technology. Contact Accumed Research Associates at 1 (888) 746-2190 or visit us and register on our website at http://www.accumedresearch.com.

Read the full story at http://www.prweb.com/releases/AccumedResearchNewsTalk/RadioShowClinicalTrials/prweb11482440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Penn research helps lay out theory for metamaterials that act as an analog computer
2. Louisiana’s First Clinical Data Research Network to Be Developed Through PCORI Funding
3. Capsugel’s Bend Research to Present New Processes for Flu Vaccine and Other Science Advancements at Upcoming Industry Meetings
4. New Insights on the Decline of Research and Development in Pharma & Biotech
5. New Jersey Health Foundation President Addresses Panel at AAHC Research Efficiency Conference
6. Cardio3 BioSciences, a European biopharmaceutical company, now covered by Edison Investment Research
7. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
8. Elsevier Launches the New Generation SciVal, Providing Dynamic Real-Time Analytics and Insights into the Global Research Landscape
9. Paraformaldehyde Industry 2014 Global & China Development Analysis in a New Research Study Available at DeepResearchReports.com
10. Researchers find that computer components can be damaged by key manufacturing processes
11. PCCI Collaborates With UTSW On Top National Research Grants Totaling Over $30 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , December 8, 2016 The report "Acrylic Processing Aid Market by ... Packaging, Automotive, Consumer Goods) - Global Forecast to 2026", published by MarketsandMarkets, the ... reach USD 1,173.6 Million by 2026, registering an of CAGR of 6.2% between ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, ... developing breakthrough immune modulatory medicines, announced today the initiation ... lead therapeutic candidate, LYC-30937- E nteric C oated, ... skin disease that is estimated to affect as many ... , with approximately 1.5 - 3 million cases ...
(Date:12/7/2016)... ... December 07, 2016 , ... JULABO USA is ... cart. The new website has been designed to provide the best user-friendly experience ... to access detailed product information, read educational industry content as well as share ...
(Date:12/6/2016)... Dec. 6, 2016 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... the fourth quarter and fiscal year ended September 30, 2016. ... , , ... life sciences and diagnostics company that develops and commercializes proprietary technologies ... Achieved revenues of $1.4 million more than tripling ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 Not many ... of the most crucial aspects of recovery so we need to do it well. ... risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... and find a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):